Sarah Aschenbrenner

Advising SENISCA on its partnership with L'Oréal

作者 Colin McCall 以及 Charlie Adams

Green Patents and ESG Innovation: The Role of the European Patent Framework

作者 Laura Coucke 以及 Adam Lybaert

The Critical Medicines Act: A New Pillar of European Pharmaceutical Resilience

作者 Alina Krukover

Life Sciences as a Security-Relevant Sector: Is Innovation at Risk under European and German FDI Control?

作者 Dr. Carolin Roßkothen, LL.M.

China’s Rare Earth Export Controls: Implications for European Life Sciences Companies

作者 Dr. Amir-Said Ghassabeh

Corporate Venturing in Life Sciences: Making Partnerships Truly Strategic

Higher Regional Court of Frankfurt am Main on online referral of doctors for the prescription of medical cannabis

作者 Dr. Daniel Tietjen 以及 Ennio Schwind, LL.M. Eur.

Request for a preliminary ruling by the BGH to the CJEU on the scope of the duty of care of medical device distributors

作者 Dr. Daniel Tietjen 以及 Daniel Dietrich

Appeal proceedings on the admissibility of granting Rx bonuses to a mail-order pharmacy based in the EU

作者 Dr. Daniel Tietjen 以及 Ennio Schwind, LL.M. Eur.

Federal Court of Justice (BGH): Placing medicinal products on the market within the meaning of Section 43 (1) of the German Medicines Act (AMG) when selling pharmacy-only medicines via the Amazon Marketplace

作者 Dr. Daniel Tietjen 以及 Daniel Dietrich